3.84
-0.03 (-0.78%)
-0.03 (-0.78%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Celsion Corp | CLSN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.03 | -0.78% | 3.84 | 3.76 | 3.93 | 3.863 | 3.87 | 09:50:26 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 3.82 | 3.84 | 0.02 | 0.52% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 525 | 166,595 | $ 3.85 | $ 641,091 | 4,366,374 | 0.6865 - 6.50 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 09:50:25 | 77 | $ 3.8388 | USD |
Celsion Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 127.56M | 33.22M | 26.81M | $ 500.00k | $ - | -0.76 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Celsion News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CLSN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.81 | 4.50 | 3.09 | 3.81 | 2,348,761 | 0.03 | 0.79% |
| 1 Month | 2.88 | 6.50 | 2.70 | 4.15 | 3,901,294 | 0.96 | 33.33% |
| 3 Months | 1.07 | 6.50 | 1.0001 | 3.45 | 2,372,644 | 2.77 | 258.88% |
| 6 Months | 1.72 | 6.50 | 0.6865 | 3.23 | 1,233,754 | 2.12 | 123.26% |
| 1 Year | 1.71 | 6.50 | 0.6865 | 3.07 | 693,518 | 2.13 | 124.56% |
| 3 Years | 1.92 | 6.50 | 0.6865 | 3.49 | 740,262 | 1.92 | 100.0% |
| 5 Years | 33.152 | 38.08 | 0.6865 | 4.62 | 708,535 | -29.31 | -88.42% |
Celsion Description
| Celsion Corp is active in the biotechnology market. The company acts as a drug developer with product candidates like ThermoDox, a heat-activated liposomal encapsulation of doxorubicin. It is in Phase III clinical trial for the treatment of primary liver cancer and a Phase II clinical trial for the treatment of recurrent chest wall breast cancer. Its pipeline also includes GEN-1, a deoxyribonucleic acid (DNA) mediated immunotherapy for the localized treatment of ovarian and brain cancers. |
